NCT06096675
- Conditions
- Amyloid Neuropathies, Amyloid Neuropathies, Familial, Amyloidosis, +16 more
- Locations
-
- Sanger Heart and Vascular Institute Charlotte, North Carolina, United States
Clinical trial condition
Proteostasis Deficiencies
Explore clinical trials studying Proteostasis Deficiencies. Study availability and eligibility vary by location and protocol.
1,350 public trials
353 recruiting studies
Proteostasis Deficiencies trial results
NCT07560306
- Conditions
- Amyloid Neuropathies, Amyloid Neuropathies, Familial, Amyloidosis, +20 more
- Locations
-
- Brigham and Women's Hospital Boston, Massachusetts, United States
NCT06855121
- Conditions
- AL Amyloidosis, Amyloidosis, Blood Protein Disorders, +23 more
- Locations
-
- Sørlandet Hospital - Arendal Arendal, Norway
- Ålesund hospital, Department of hematology Ålesund, Norway
- Haukeland University Hospital Bergen, Norway
- Bodø Hospital Bodø, Norway
NCT06719947
- Conditions
- Amyotrophic Lateral Sclerosis, Amyotrophic Lateral Sclerosis (ALS), Central Nervous System Diseases, +9 more
- Locations
-
- Universidade de Brasília - Campus Ceilândia Brasília, Federal District, Brazil
- PneumoCardioVascular Lab - HUOL/UFRN Natal, Rio Grande do Norte, Brazil
- Universidad Autónoma de Chile Santiago, Santiago Metropolitan, Chile
- Universidad do Chile Santiago, Santiago Metropolitan, Chile
Recruiting
A Study of Donanemab (LY3002813) in Participants With Early Cognitive Decline (TRAILBLAZER-ALZ 7)
NCT07589595
- Conditions
- Alzheimer Disease, Amyloid, Basal Ganglia Diseases, +17 more
- Locations
-
- TrialSphere Corp Chandler, Arizona, United States
- HonorHealth Research Institute Scottsdale, Arizona, United States
- Profound Research LLC Carlsbad, California, United States
- Irvine Clinical Research Irvine, California, United States
- Conditions
- Amyloidosis, Immune System Diseases, Immunoglobulin Light-chain Amyloidosis, +9 more
- Locations
-
- GSK Investigational Site Rochester, Minnesota, United States
- GSK Investigational Site Westmead, New South Wales, Australia
- GSK Investigational Site Woolloongabba, Queensland, Australia
- GSK Investigational Site Box Hill, Victoria, Australia
NCT07571174
- Conditions
- Amyotrophic Lateral Sclerosis, Central Nervous System Diseases, Metabolic Diseases, +8 more
- Locations
-
- UZ Leuven Leuven, Belgium
- University Hospital - London Health Sciences Centre London, Canada
- McGill University Health Centre Montreal, Canada
- Sunnybrook Research Institute Toronto, Canada
NCT07571200
- Conditions
- Amyotrophic Lateral Sclerosis, Central Nervous System Diseases, Metabolic Diseases, +8 more
- Locations
-
- UZ Leuven Leuven, Belgium
- University Hospital - London Health Sciences Centre London, Canada
- McGill University Health Centre Montreal, Canada
- Sunnybrook Research Institute Toronto, Canada
NCT06393712
- Conditions
- Amyloidosis, Brain Diseases, Cardiovascular Diseases, +10 more
- Locations
-
- Clinical Trial Site Los Angeles, California, United States
- Clinical Trial Site Orange, California, United States
- Clinical Trial Site Palo Alto, California, United States
- Clinical Trial Site Sacramento, California, United States
Recruiting
Teclistamab-Daratumumab in AL Amyloidosis
NCT07110844
- Conditions
- Amyloid Light-chain Amyloidosis, Amyloidosis, Immune System Diseases, +10 more
- Locations
-
- Boston Medical Center Boston, Massachusetts, United States
- Columbia University Irving Medical Center New York, United States
- Medical College of Wisconsin Milwaukee, Wisconsin, United States